Group,Number,Sex,"Age (years; mean ± SD, median, range","MMSE (mean ± SD, median, range)","Barthel index score (mean ± SD, median, range)","Time‐ratio??? (mean ± SD, median, range)","Total disease duration (months; mean ± SD, median, range)",Codon 129 (n = 37),Molecular classification???,Molecular classification???
Unnamed: 0_level_1,Unnamed: 1_level_1,Unnamed: 2_level_1,Unnamed: 3_level_1,Unnamed: 4_level_1,Unnamed: 5_level_1,Unnamed: 6_level_1,Unnamed: 7_level_1,Unnamed: 8_level_1,Type??? (n = 27; 73%),n (%)
HC,30,15F (50%)15M (50%),63.4 ± 10.566.5 [45–78],29.36 ± 1.0330 [26–30],N/D,,,,,
sCJD,37,17F (46%)20M (54%),64 ± 7.865 [46–82],16 ± 8.518 [0–27],63.7 ± 3770 [0–100],0.64 ± 0.250.71 [0.11–0.99],16.27 ± 8.1917 [3–34],"MM (n = 12, 32.4%)",MM1MM2CMM1‐2CMM N/A,1 (2.7%)7 (18.9%)2 (5.4%)2 (5.4%)
sCJD,37,17F (46%)20M (54%),64 ± 7.865 [46–82],16 ± 8.518 [0–27],63.7 ± 3770 [0–100],0.64 ± 0.250.71 [0.11–0.99],16.27 ± 8.1917 [3–34],"MV (n = 18, 48.6%)",MV1MV2CMV2KMV2K+CMV1‐2MV N/A,4 (10.8%)4 (10.8%)2 (5.4%)1 82.7%)2 (5.4%)4 (10.8%)
sCJD,37,17F (46%)20M (54%),64 ± 7.865 [46–82],16 ± 8.518 [0–27],63.7 ± 3770 [0–100],0.64 ± 0.250.71 [0.11–0.99],16.27 ± 8.1917 [3–34],"VV (n = 7, 19%)",VV1VV2VV1‐2VV N/A,1 (2.7%)3 (8.1%)1 (2.7%)2 (5.4%)
